(Q28301776)
Statements
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels (English)
0 references
November 2004
0 references
32
0 references
2173-82
0 references
11
0 references